Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
118.97
-0.50 (-0.42%)
At close: Dec 20, 2024, 4:00 PM
119.30
+0.33 (0.28%)
After-hours: Dec 20, 2024, 5:02 PM EST
Sarepta Therapeutics Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$179.38
Upside
+50.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $75 | Strong Sell | Reiterates | $75 | -36.96% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Maintains $80 → $75 | Strong Sell | Maintains | $80 → $75 | -36.96% | Dec 3, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $200 → $182 | Buy | Maintains | $200 → $182 | +52.98% | Nov 27, 2024 |
| Needham | Needham | Strong Buy Maintains $205 → $202 | Strong Buy | Maintains | $205 → $202 | +69.79% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Initiates $80 | Strong Sell | Initiates | $80 | -32.76% | Nov 25, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $148 → $150 | Strong Buy | Maintains | $148 → $150 | +26.08% | Nov 7, 2024 |
| Baird | Baird | Buy Maintains $200 → $193 | Buy | Maintains | $200 → $193 | +62.23% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $152 → $167 | Hold → Buy | Upgrades | $152 → $167 | +40.37% | Nov 7, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $179 → $170 | Buy | Maintains | $179 → $170 | +42.89% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $205 | Strong Buy | Reiterates | $205 | +72.31% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $182 | Buy | Reiterates | $182 | +52.98% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $165 | Strong Buy | Initiates | $165 | +38.69% | Oct 21, 2024 |
| Needham | Needham | Strong Buy Reiterates $205 | Strong Buy | Reiterates | $205 | +72.31% | Oct 14, 2024 |
| Raymond James | Raymond James | Buy Initiates $150 | Buy | Initiates | $150 | +26.08% | Oct 10, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $181 → $182 | Buy | Maintains | $181 → $182 | +52.98% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $152 | Hold | Reiterates | $152 | +27.76% | Sep 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.